20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is PIRFENIDONE, with a corresponding US DMF Number 32304.
Remarkably, this DMF maintains an Active status since its submission on December 21, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 20, 2018, and payment made on December 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II